pain relief after nerve block in upper abdominal cancer patients

Patient related outcome measures (PROMs) following splanchnic nerve neurolysis in the management of upper abdominal cancer pain -A Prospective observational study - nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106401

Enrollment

Registered

2026-03-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

Intervention1: Nil: Nil Intervention2: Splanchnic nerve block in upper abdominal cancer patients: To study the efficacy and pain releif after splanchnic nerve block in upper abdominal cancer patients

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age more than 18 years with intractable abdominal pain secondary to intra-abdominal malignancies 2.expected life expectancy more than 2 months 3.ability to give informed written consent 4.comply to follow up

Exclusion criteria

Exclusion criteria: 1.Age less than 18 yrs 2.surgically performed chemical splanchnicectomy 3.coagulopathy 4.local infection 5.known allergy to materials used

Design outcomes

Primary

Measure	Time frame
To evaluate the analgesic efficacy of Neurolytic Splanchnic Nerve Block in patients with intractable upper abdominal pain secondary to intra-abdominal malignancies.Timepoint: 1 hour 24 hours 1 week 2 weeks 4 weeks 8 weeks 12 weeks 24 weeks	—

Secondary

Measure	Time frame
To assess the effect of NSNB on quality of life.To determine the reduction in daily opioid consumption following the procedure.To evaluate the procedural safety incidence of complications and adverse effects.To analyse patient survival outcomes following splanchnic nerve neurolysisTimepoint: 1 hour 24 hours 1 week 2 weeks 4 weeks 8 weeks 12 weeks 24 weeks	—

Countries

India

Contacts

Public ContactDr Senthil kumar MD DA

Institute of Anaesthesiology,madurai medical college

drthendral29@gmail.com9842188722

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026